NCT05576454 Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT05518695 Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT05439629 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration Status COMPLETED Phase PHASE3
NCT05414136 Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 Status COMPLETED Phase PHASE1
NCT05405621 Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 Status UNKNOWN Phase PHASE1
NCT05378737 Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection Status COMPLETED Phase PHASE1
NCT05377944 Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients Status COMPLETED Phase PHASE3
NCT05332730 A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® Status COMPLETED Phase PHASE1
NCT05180526 Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05155722 Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05148325 Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05141994 Clinical Study on the Efficacy and Safety of BAT5906 Injection Status COMPLETED Phase PHASE2
NCT05120375 Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China Status TERMINATED Phase PHASE1
NCT05116709 Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT05109650 Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients Status TERMINATED Phase PHASE1
NCT05105971 Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China Status COMPLETED Phase PHASE1
NCT05073484 Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients Status TERMINATED Phase PHASE1
NCT05046431 Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT04772105 Clinical Study of the Safety and Efficacy of BAT5906 Injection Status COMPLETED Phase PHASE1/PHASE2